Q1 2025 · 13F-HR
22NW, LPholdings as filed
Filed 2025-05-14 · accession 0001214659-25-007607
$149.1M
Reported value
20
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 514766104 | LFCR | LIFECORE BIOMEDICAL INC | $29.8M | 20.0% | 1,755,161 | Common | SOLE |
| 350060109 | FSTR | FOSTER L B CO | $25.8M | 17.3% | 1,313,121 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $20.1M | 13.5% | 15,467,300 | Common | SOLE |
| 859241101 | STRL | STERLING INFRASTRUCTURE INC | $11.3M | 7.58% | 99,783 | Common | SOLE |
| 230215105 | CULP | CULP INC | $9.3M | 6.23% | 1,859,061 | Common | SOLE |
| 86183P102 | SRI | STONERIDGE INC | $7.5M | 5.01% | 1,627,653 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $7.3M | 4.91% | 461,344 | Common | SOLE |
| 71742W103 | PFX | PHENIXFIN CORP | $6.2M | 4.19% | 117,885 | Common | SOLE |
| 068463108 | BBSI | BARRETT BUSINESS SVCS INC | $5.5M | 3.66% | 132,452 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $4.8M | 3.21% | 668,679 | Common | SOLE |
| 307675108 | FB1 | FARMER BROS CO | $4.3M | 2.91% | 1,955,526 | Common | SOLE |
| 23331S100 | DHX | DHI GROUP INC | $3.6M | 2.43% | 2,603,643 | Common | SOLE |
| 904677200 | UFI | UNIFI INC | $3.5M | 2.36% | 731,535 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $2.2M | 1.45% | 636,364 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.8M | 1.24% | 646,559 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.8M | 1.22% | 179,000 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.5M | 1.00% | 2,191,750 | Common | SOLE |
| 86272A305 | SSKN | STRATA SKIN SCIENCES INC | $1.4M | 0.95% | 536,995 | Common | SOLE |
| 744375205 | PMDUSD | PSYCHEMEDICS CORPORATION CMN | $643,159 | 0.43% | 276,034 | Common | SOLE |
| 878155308 | TISI | TEAM INC | $589,408 | 0.40% | 34,835 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.